Author:
Singh H O,Lata S,Angadi M,Bapat S,Pawar J,Nema V,Ghate M V,Sahay S,Gangakhedkar R R
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference42 articles.
1. Carr A, Cooper DA . Adverse effects of antiretroviral therapy. Lancet 2001; 356: 1423–1430.
2. Van Dyke RB, Wang L, Williams PL . Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 2008; 198: 1599–1608.
3. Van leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B . Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomized open-label trial, the study. Lancet 2004; 363: 1253–1263.
4. Reisler R, Liou S, Servoss J, Robbins G, Theodore D, Murphy R et al Incidence of hepatotoxicity and mortality in 21 adult antiretroviral treatment trials. Program and abstracts of The 1st IAS Conference on HIV Pathogenesis and Treatment; Buenos Aires, Argentina. MEDLINE Abstracts 43. July 8–11, 2001.
5. Nagpal M, Tayal V, Kumar S, Gupta U . Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: a prospective observational study. Indian J Med Sci 2010; 64: 245–252.